High-Risk Patient Hybrid Coronary Revascularization for Cardiogenic Shock

May 4, 2016

Hofstra-Northwell School of Medicine’s Dr. Michael Happes shares a Protected PCI case that involved complex decision making and demonstrated the value of Impella® supported PCI in cardiogenic shock under difficult circumstances. (Tweet This)


To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: www.protectedpci.com/indications-use-safety-information/